-
Rollout of ‘miracle’ HIV prevention drug is threatened by Trump cuts to global AIDS relief program
01 Apr 2025 12:23 GMT
… widely shared goal to eradicate HIV and AIDS by 2030. For this … such injectable is sold by ViiV Healthcare, although it must be administered … tide in the fight against HIV/AIDS… The science has given … us the tools to fight HIV, …
-
Meet the 'queer' radicals who secretly send kids sex-change kits
04 Apr 2025 20:32 GMT
… spread by same-sex contact; Viiv Healthcare, an AIDS-focused medical company; Funders …
-
EIGHTH EDITION OF THE RED DRESS BALL SET TO SHINE IN SUPPORT OF PEOPLE LIVING WITH HIV
31 Mar 2025 13:04 GMT
… living with HIV. Backed by founding sponsors ViiV Healthcare and DCM, … through the Toronto People With AIDS Foundation (PWA Toronto).
… Hebert, General Manager of ViiV Healthcare Canada. “This event fosters … continuing impact of HIV/AIDS in Canada and …
-
ViiV Healthcare Presents Potential Long-Acting HIV Therapies
17 Mar 2025 15:19 GMT
… , we spoke with researchers from ViiV Healthcare about the latest findings from … HIV.
Luise Rogg, MD, PhD, discovery medicine lead for VH184 at ViiV Healthcare … VH499 move through clinical development, ViiV Healthcare's researchers acknowledge that …
-
HIV Drugs Global Strategic Business Report 2025 Featuring Over 50 Key Players - Global Market Forecasts to 2030 - ResearchAndMarkets.com
28 Mar 2025 18:11 GMT
… ;s Emergency Plan for AIDS Relief (PEPFAR) and the … Global Fund to Fight AIDS, Tuberculosis and Malaria, … reach and effectiveness of HIV care.
HIV drugs have revolutionized …
Teva Pharmaceutical Industries Ltd.
ViiV Healthcare
For more information about this …
-
GSK Wins FDA Nod for First Oral UTI Antibiotic in Almost 30 Years
26 Mar 2025 14:01 GMT
… diarrhea and nausea.
GSK Chief Scientific Officer Tony … recurrent episode.
Elsewhere in GSK’s infectious disease franchise … ViiV Healthcare-partnered long-acting antiviral drugs VH499 and VH184 in HIV … the FDA ordered GSK—alongside Pfizer—to amend the label …
-
CROI 2025: Key Updates on ViiV Healthcare’s Cabenuva and Apretude
17 Mar 2025 16:21 GMT
…
REFERENCES
1. ViiV Healthcare. ViiV Healthcare continues to deliver long-acting injectable HIV innovation with … -cabenuva-and-vocabria-treatment-hiv-1-infection
3. ViiV Healthcare. ViiV Healthcare announces new implementation …
-
Broadly Neutralizing Antibodies Show Promise for Long-Acting HIV Treatment
24 Mar 2025 13:12 GMT
… cabotegravir. People living with HIV normally produce HIV-specific antibodies, but these … study, Babafemi Taiwo, MBBS, of ViiV Healthcare, and colleagues evaluated the safety … with hyaluronidase, an enzyme that aids absorption and enables higher dosing …
-
In-Depth Analysis Of The Global Acquired Immunodeficiency Syndrome (AIDS) Market: Key Drivers, Trends, Growth
24 Mar 2025 10:53 GMT
… injectable and implantable HIV treatments, the swelling … charge in the AIDS market include Pfizer Inc., Johnson … Squibb Company, Abbott, GSK plc, Takeda Pharmaceuticals, … Glenmark Pharmaceuticals Limited, ViiV Healthcare.
A significant trend observed …
-
ViiV Healthcare showcases leadership in long-acting injectables innovation at CROI 2025 with data on third-generation integrase inhibitor and highly potent capsid inhibitor against HIV-1
13 Mar 2025 09:11 GMT
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as … achieving our ambition of ending HIV and AIDS. Our pipeline with INSTIs …
About
© 1995-2025